Data from a meta-analysis published recently in The Lancet found that extended-duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with significantly higher rates of mortality compared to shorter DAPT.

Use of computed tomography coronary angiography (CTA), which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in patients presenting with chest pain. This has led to more appropriate follow-up testing and treatments, according to research presented at the American College of Cardiology (ACC) 2015 Annual Scientific Session. Data also showed a trend toward a lower incidence of heart attacks among the group receiving CT scans, compared to usual care.

The American College of Cardiology (ACC) hosted its 64th Annual Scientific Session & Expo over the weekend in San Diego, California. Key data from multiple transcatheter aortic valve replacement (TAVR) clinical trials were presented and we believe there was truly no loser between Edwards and Medtronic based on the positive data presented. In addition, St. Jude Medical announced retrospective analysis on CHAMPION data showing significant reduction in mortality rates and heart failure (HF) hospitalizations for heart failure patients with reduced ejection fraction.

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart surgery, though valve leakage was more common with the first-generation valve evaluated in this study than with surgery, according to research from PARTNER I presented at the American College of Cardiology’s (ACC) 2015 Annual Scientific Session.